reference/7294597

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7294597

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	588
issn	1029-2403 1042-8194
issueIdentifier	4
pageRange	581-588
publicationName	Leukemia & Lymphoma
startingPage	581
bibliographicCitation	Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Tucci A, Ilariucci F, Chiappella A, Musso M, Di Rocco A, Stelitano C, Alvarez I, Baldini L, Mazza P, Salvi F, Arcari A, Fragasso A, Gobbi PG, Liberati AM, Federico M. Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly \"fit\" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi. Leuk Lymphoma. 2012 Apr;53(4):581–8. doi: 10.3109/10428194.2011.621565. PMID: 21895543.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e74d53c43378236ef7fa278d60b0b8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4279-3358 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a25ebf300f49d086b310f2d3ae2f83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5074-3262 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e54f4e8aeadca235588922ddf61e9c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48470798df7722d660473a584eb4a6c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ba30dddbf3a8c55606bf2e09e0c44ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2977-0098 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48736f755de4b2203913bcd75c8bc722 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6597853ec76d3f44d563d45a2fbabb5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8446-2285 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7550fe79f6a4bf84cb37f3d0be9281f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be1ce8ea5af632b95e29adf90e09764e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9889-3796 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_601823f6172f7a8c985719f1819f5a61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd023fbe62d76f2ac212e563fa9d1cfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce848e19c26ef938beada73a7519f9d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fac889e29914cc68699bf18a91a6b8a7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0979-7883 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f224af76f08393ba839ba9c0e70b952 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f13b33e4d073017cd9963fe458d7c90 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2964-9981 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c419a48d365c80def1e744848a53d9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0fe6df0887097737af0e51cc2d04f0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6bf3d176bf27d3baed9fc02564a17ce7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2cade75a9e4c0bb608ded2bd0c4c101 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1520-2970 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3052-7463 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f381d0c0ac2974e5d808e46bc6e1539b
date	201204
identifier	https://doi.org/10.3109/10428194.2011.621565 https://pubmed.ncbi.nlm.nih.gov/21895543
isPartOf	https://portal.issn.org/resource/ISSN/1042-8194 https://portal.issn.org/resource/ISSN/1029-2403 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2306
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly “fit” patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi
discusses	http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0023488 http://id.nlm.nih.gov/mesh/M0544940 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0022676
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015999 http://id.nlm.nih.gov/mesh/D000740Q000139 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D014750Q000009 http://id.nlm.nih.gov/mesh/D015577Q000706 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D058846Q000009 http://id.nlm.nih.gov/mesh/D058846Q000008 http://id.nlm.nih.gov/mesh/D015251Q000009 http://id.nlm.nih.gov/mesh/D003520Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D015577Q000379 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009503Q000139 http://id.nlm.nih.gov/mesh/D004317Q000009 http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D016403Q000473 http://id.nlm.nih.gov/mesh/D015251Q000008 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D016016 http://id.nlm.nih.gov/mesh/D011241Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011446
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536

Total number of triples: 113.